Publications

Asthma Is Associated With Subsequent Development of Inflammatory Bowel Disease: A Population-based Case-Control Study.
Clin Gastroenterol Hepatol 2017 Sep 23;15(9):1405-1412.e3. Epub 2017 Mar 23.
Department of Medicine, University of Calgary, Calgary, Alberta, Canada; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada; Synder Institute for Chronic Diseases, University of Calgary, Calgary, Alberta, Canada; O'Brien Institute for Public Health, University of Calgary, Calgary, Alberta, Canada. Electronic address:

The SPECTRA Collaboration OMERACT Special Interest Group: Current Research and Future Directions.
J Rheumatol 2017 Aug 1. Epub 2017 Aug 1.
From the Institute for Biomechanics, ETH Zurich, Zurich, Switzerland; Department of Biomedical Engineering, University of Melbourne, Melbourne, Victoria, Australia; Department of Rheumatology and Clinical Immunology, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Departments of Medicine and Community Health Sciences, University of Calgary; McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, Canada. PGC is supported in part by the NIHR Leeds Biomedical Research Centre. K.S. Stok, PhD, Senior Lecturer, Institute for Biomechanics, ETH Zurich, and Department of Biomedical Engineering, University of Melbourne; S. Finzel, MD, Senior Attending Physician, Department of Rheumatology and Clinical Immunology, Faculty of Medicine, University of Freiburg; A.J. Burghardt, BS, Research Specialist, Department of Radiology and Biomedical Imaging, University of California; P.G. Conaghan, MD, PhD, Professor, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Biomedical Research Centre; C. Barnabe, MD, MSc, Associate Professor, Departments of Medicine and Community Health Sciences, University of Calgary, and McCaig Institute for Bone and Joint Health, University of Calgary. Address correspondence to Dr. K.S. Stok, Department of Biomedical Engineering, University of Melbourne, Parkville, Victoria, 3010, Australia. E-mail: Accepted for publication June 3, 2017.

The NOD2-Smoking Interaction in Crohn's Disease is likely Specific to the 1007fs Mutation and may be Explained by Age at Diagnosis: A Meta-Analysis and Case-Only Study.
EBioMedicine 2017 Jul 16;21:188-196. Epub 2017 Jun 16.
Department of Medicine, University of Calgary, Calgary, Alberta, Canada; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada; O'Brien Institute for Public Health, University of Calgary, Calgary, Alberta, Canada; Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada; (i)Alberta Inflammatory Bowel Disease Consortium, University of Calgary, Calgary, Alberta, Canada. Electronic address:

Mortality causes and outcomes in Indigenous populations of Canada, the United States, and Australia with rheumatic disease: A systematic review.
Semin Arthritis Rheum 2017 Jul 25. Epub 2017 Jul 25.
Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada. Electronic address:

Depression Is Associated with an Increased Risk of Psoriatic Arthritis among Patients with Psoriasis: A Population-Based Study.
J Invest Dermatol 2017 Apr 22;137(4):828-835. Epub 2017 Feb 22.
Department of Community Health Sciences, Cumming School of Medicine, Calgary, Alberta, Canada; Division of Rheumatology, Cumming School of Medicine, Calgary, Alberta, Canada. Electronic address:

Stand Up and Be Counted: Measuring and Mapping the Rheumatology Workforce in Canada.
J Rheumatol 2017 Feb 1;44(2):248-257. Epub 2016 Dec 1.
From the Division of Rheumatology, Department of Medicine, University of Calgary, Cumming School of Medicine, McCaig Institute for Bone and Joint Health; Department of Geography, and Department of Community Health Sciences, University of Calgary, Calgary; Division of Pediatric Rheumatology, Faculty of Medicine and Dentistry, University of Alberta; Division of Rheumatology, Department of Medicine, University of Alberta, Edmonton, Alberta; Arthritis Research Canada, Richmond; Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, British Columbia; Krembil Research Institute, Toronto Western Hospital; Dalla Lana School of Public Health, University of Toronto; Hospital for Sick Children; Pediatrics, University of Toronto; Faculty of Medicine, University of Toronto, Toronto; Rheumatology, McMaster University, Hamilton; William Osler Health System, Brampton; Private Practice, Kingston; Canadian Rheumatology Association; The Arthritis Program at Southlake Regional Health Centre, Newmarket; Division of Rheumatology, University of Western Ontario, London; Department of Medicine, Division of Rheumatology, University of Ottawa, Ottawa; Private Practice, Guelph; Private Practice, Markham, Ontario; University of Manitoba, Winnipeg, Manitoba; Rheumatology, Hôpital Maisonneuve-Rosemont; Université de Montréal, Montreal, Quebec; University of Saskatchewan, Regina, Saskatchewan, Canada.

Health Equity Considerations for Developing and Reporting Patient-reported Outcomes in Clinical Trials: A Report from the OMERACT Equity Special Interest Group.
J Rheumatol 2017 Feb 15. Epub 2017 Feb 15.
From the Bruyère Research Institute, University of Ottawa; Ottawa Hospital Research Institute and School of Epidemiology, Public Health and Preventative Medicine, University of Ottawa; Cochrane Musculoskeletal Group, University of Ottawa; Children's Hospital of Eastern Ontario Research Institute; Department of Pediatrics and School of Rehabilitation Sciences, University of Ottawa; Department of Medicine, Faculty of Medicine, University of Ottawa; Ottawa Hospital Research Institute, Clinical Epidemiology Program; Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa, Ottawa; Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital; Institute for Work and Health; Occupational Science and Occupational Therapy, Rehabilitation Sciences Institute, Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario; Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, Alberta; Division of Rheumatology Department of Medicine, University of British Columbia (UBC); Department of Occupational Science and Occupational Therapy, Faculty of Medicine, UBC, Vancouver; Arthritis Research Canada, Richmond; Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada; Veterans Affairs Portland Health Care System, Oregon Health and Science University, Portland, Oregon; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; Quintiles IMS, Denver, Colorado; Department of Medicine, Rheumatology Division, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; University of Alabama at Birmingham; Birmingham Veterans Affairs Medical Center, Birmingham, Alabama; Department of Orthopedics, Mayo Clinic College of Medicine, Rochester, Minnesota; Penn Vasculitis Center, Division of Rheumatology, The University of Pennsylvania, Philadelphia, Pennsylvania, USA; University of the West of England, Bristol, UK; VU University Medical Centre, Department Medical Humanities, EMGO+ Research Institute, Amsterdam; Department Internal Medicine, Division of Rheumatology, Maastricht University Medical Center; Caphri Graduate School Maastricht University, Maastricht, the Netherlands; Musculoskeletal Statistics Unit, The Parker Institute; Frederiksberg Hospital, Copenhagen, Denmark; Department Internal Medicine II, Rheumatology, Schlosspark-Klinik Berlin, Charité - Medical University Berlin, Berlin, Germany; Monash Department of Clinical Epidemiology, Cabrini Institute and Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia; University of Lorraine, Nancy, France. J.A. Singh has received research grants from Takeda and Savient, and consultant fees from Savient, Takeda, Regeneron, Merz, Iroko, Bioiberica, Crealta and Allergan pharmaceuticals, WebMD, UBM LLC, and the American College of Rheumatology. J.A. Singh serves as the principal investigator for an investigator-initiated study funded by Horizon pharmaceuticals through a grant to DINORA Inc., a 501 (c)(3) entity. J.A. Singh is a member of the executive of OMERACT, an organization that develops outcome measures in rheumatology and receives arms-length funding from 36 companies; a member of the American College of Rheumatology's (ACR) Annual Meeting Planning Committee; Chair of the ACR Meet-the-Professor Workshop and Study Group Subcommittee; and a member of the Veterans Affairs Rheumatology Field Advisory Committee. C. Bartels receives institutional peer-reviewed grant support from Independent Grants for Learning and Change (Pfizer) unrelated to this work. J. Petkovic, MSc, Bruyère Research Institute, University of Ottawa; J.L. Barton, MD, Veterans Affairs Portland Health Care System, Oregon Health and Science University; C. Flurey, PhD, University of the West of England; N. Goel, MD, Division of Rheumatology, Duke University School of Medicine, and Advisory Services, Quintiles IMS, and Patient Research Partner; C.M. Bartels, MD, MS, Department of Medicine, Rheumatology Division, University of Wisconsin School of Medicine and Public Health; C. Barnabe, MD, Departments of Medicine and Community Health Sciences, University of Calgary; M.P. de Wit, PhD, Patient Researcher, VU University Medical Centre, Department Medical Humanities, EMGO+ Research Institute; A. Lyddiatt, Patient Research Partner; D. Lacaille, MD, MHSc, Professor, Division of Rheumatology Department of Medicine, UBC, and Senior Scientist, Arthritis Research Canada; V. Welch, PhD, Bruyère Research Institute, University of Ottawa; A. Boonen, MD, PhD, Department Internal Medicine, Division of Rheumatology Maastricht, University Medical Center, and Caphri Graduate School Maastricht University; B. Shea, PhD, Ottawa Hospital Research Institute and School of Epidemiology, Public Health and Preventative Medicine, University of Ottawa; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, and Frederiksberg Hospital; L.J. Maxwell, PhD, Cochrane Musculoskeletal Group, University of Ottawa; W. Campbell, LLB, Patient Research Partner; J. Jull, PhD, Bruyere Research Institute; K. Toupin-April, PhD, Children's Hospital of Eastern Ontario Research Institute, and Department of Pediatrics and School of Rehabilitation Sciences, University of Ottawa; J.A. Singh, MBBS, MPH, Professor of Medicine and Epidemiology, University of Alabama at Birmingham, and Staff Physician, Birmingham Veterans Affairs Medical Center, and Research Collaborator, Department of Orthopedics, Mayo Clinic College of Medicine; C.H. Goldsmith, BSc, MSc, PhD, Faculty of Health Sciences, Simon Fraser University, and Adjunct Professor, Department of Occupational Science and Occupational Therapy, Faculty of Medicine, UBC; A.G. Sreih, MD, Penn Vasculitis Center, Division of Rheumatology, The University of Pennsylvania; C. Pohl, MD, Department of Internal Medicine II, Rheumatology, Schlosspark-Klinik Berlin, University Medicine Berlin; C. Hofstetter, Patient Research Partner; D.E. Beaton, PhD, Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Institute for Work and Health, and Occupational Science and Occupational Therapy, Rehabilitation Sciences Institute, Institute of Health Policy Management and Evaluation, University of Toronto; R. Buchbinder, PhD, Monash Department of Clinical Epidemiology, Cabrini Institute and Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University; F. Guillemin, MD, PhD, University of Lorraine; P.S. Tugwell, MD, MSc, Department of Medicine, Faculty of Medicine, University of Ottawa, and Ottawa Hospital Research Institute, Clinical Epidemiology Program, and Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa, Ottawa. Address correspondence to Dr. J. Petkovic, 43 Bruyère St., Annex E, Room 302, Ottawa, Ontario K1N 5C8, Canada. E-mail: Accepted for publication January 11, 2017.

Lifetime risk of diabetes among First Nations and non-First Nations people.
CMAJ 2016 Nov 19;188(16):1147-1153. Epub 2016 Sep 19.
Department of Family Medicine (Turin), Department of Community Health Sciences (Turin, Manns, Hemmelgarn), Institute of Public Health (Turin, Manns, Hemmelgarn) and Department of Medicine (Saad, Jun, Tonelli, Ma, Barnabe, Manns, Hemmelgarn), University of Calgary, Calgary, Alta.

Gaps in Addressing Cardiovascular Risk in Rheumatoid Arthritis: Assessing Performance Using Cardiovascular Quality Indicators.
J Rheumatol 2016 Nov 1;43(11):1965-1973. Epub 2016 Aug 1.
From the Division of Rheumatology, Department of Medicine, and Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary; Alberta Health Services, Alberta; Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver; Arthritis Research Canada, Richmond, British Columbia; University of Toronto, Toronto, Ontario, Canada; University of Queensland, Brisbane, Australia.

Heterogeneity of Cortical Breaks in Hand Joints of Patients with Rheumatoid Arthritis and Healthy Controls Imaged by High-resolution Peripheral Quantitative Computed Tomography.
J Rheumatol 2016 Oct;43(10):1914-1920
From the Department of Medicine, Division of Rheumatology, Maastricht University Medical Center (MUMC); CAPHRI, School for Public Health and Primary Care; NUTRIM, School for Nutrition and Translational Research in Metabolism, Maastricht, the Netherlands; Department of Internal Medicine, Viecuri Medical Center, Venlo, the Netherlands; Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium; Medicine and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada; Department of Rheumatology and Clinical Immunology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Faculty of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands.A. Scharmga, MSc, Department of Medicine, Division of Rheumatology, MUMC, CAPHRI, and NUTRIM; M. Peters, MSc, Department of Medicine, Division of Rheumatology, MUMC, CAPHRI, and NUTRIM; A. van Tubergen, MD, PhD, Department of Medicine, Division of Rheumatology, MUMC, and CAPHRI; J. van den Bergh, MD, PhD, Department of Internal Medicine, Viecuri Medical Center, NUTRIM, and Faculty of Medicine and Life Sciences, Hasselt University; C. Barnabe, MD, PhD, FRCPC, Medicine and Community Health Sciences, University of Calgary; S. Finzel, MD, Department of Rheumatology and Clinical Immunology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg; B. van Rietbergen, PhD, Faculty of Biomedical Engineering, Eindhoven University of Technology; P. Geusens, MD, PhD, Faculty of Medicine and Life Sciences, Hasselt University, and CAPHRI.

Determining Metacarpophalangeal Flexion Angle Tolerance for Reliable Volumetric Joint Space Measurements by High-resolution Peripheral Quantitative Computed Tomography.
J Rheumatol 2016 Oct;43(10):1941-1944
From the Department of Medicine, Faculty of Medicine, University of Toronto, Toronto; Department of Mechanical Engineering, University of Waterloo, Waterloo, Ontario; McCaig Institute for Bone and Joint Health, University of Calgary; the departments of Radiology and Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Musculoskeletal Quantitative Imaging Research Group, Department of Radiology and Biomedical Imaging, University of California at San Francisco, San Francisco, California, USA; Institute for Biomechanics, ETH Zurich, Zurich, Switzerland; Schulich School of Engineering, University of Calgary; Faculty of Kinesiology, and Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.S. Tom, MD, Rheumatology Resident, Department of Medicine, Faculty of Medicine, University of Toronto; M. Frayne, Bachelor of Applied Science Student, Mechanical Engineering, Department of Mechanical Engineering, University of Waterloo, and McCaig Institute for Bone and Joint Health, University of Calgary; S.L. Manske, PhD, Research Associate, McCaig Institute for Bone and Joint Health, University of Calgary, and Department of Radiology, Cumming School of Medicine, University of Calgary; A.J. Burghardt, BS, Research Specialist, Musculoskeletal Quantitative Imaging Research Group, Department of Radiology and Biomedical Imaging, University of California San Francisco; K.S. Stok, PhD, Senior Research Associate, Institute for Biomechanics, ETH Zurich; S.K. Boyd, PhD, Professor, Department of Radiology, McCaig Institute for Bone and Joint Health, and Department of Radiology, Cumming School of Medicine, and Schulich School of Engineering, and Faculty of Kinesiology, University of Calgary; C. Barnabe, MD, MSc, Assistant Professor, Department of Medicine and Department of Community Health Sciences, and McCaig Institute for Bone and Joint Health, University of Calgary.

Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis: A network meta-analysis.
Cochrane Database Syst Rev 2016 Aug 29(8):CD010227. Epub 2016 Aug 29.
Department of Medicine and Department of Community Health Sciences, University of Calgary, 3330 Hospital Drive NW, Calgary, ON, Canada, T2N 1N1.

Fine particulate air pollution and systemic autoimmune rheumatic disease in two Canadian provinces.
Environ Res 2016 Apr 24;146:85-91. Epub 2015 Dec 24.
Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Purvis Hall 1020 Pine Avenue West, Montreal, QC, Canada H3A 1A2; Division of Clinical Epidemiology, McGill University Health Centre, Royal Victoria Hospital, V Pavilion 687, Pine Avenue West, Montreal, QC, Canada H3A 1A1.


Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis.
BMJ 2016 Apr 21;353:i1777. Epub 2016 Apr 21.
Department of Medicine and Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada, M5G2C4 Toronto General Research Institute, University Health Network, Toronto, ON, Canada, M6J3S3 Mount Sinai Hospital, Division of Rheumatology, Toronto, ON, Canada, M5T3L9.

Toward Ensuring Health Equity: Readability and Cultural Equivalence of OMERACT Patient-reported Outcome Measures.
J Rheumatol 2015 Dec 15;42(12):2448-59. Epub 2015 Jun 15.
From the Centre for Global Health, University of Ottawa, Ottawa, Ontario, Canada; University of Lorraine, EA 4360 Apemac, Nancy, France; Cabrini Institute and Monash University, Melbourne, Australia; Bruyère Research Institute, and the Institute of Population Health, University of Ottawa, Ottawa, Ontario, Canada; Faculty of Medicine, Nursing and Health Sciences, Monash University, Australia; Musculoskeletal Statistics Unit, The Parker Institute, Department of Rheumatology, Copenhagen University Hospitals, Bispebjerg and Frederiksberg, Denmark; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University, Maastricht, The Netherlands; Quintiles Inc.; Division of Rheumatology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA; Children's Hospital of Eastern Ontario Research Institute, Department of Pediatrics, University of Ottawa, Ottawa, Ontario, Canada; VU Medical Centre, Amsterdam, The Netherlands; University of California at San Francisco, San Francisco, California, USA; Faculty of Health and Applied Sciences, University of the West of England, Bristol, UK; Departments of Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Department of Internal Medicine II Rheumatology, Clinical Immunology, Osteology, Physical Therapy and Sports Medicine, Schlosspark-Klinik, Teaching Hospital of the Charité, University Medicine Berlin, Berlin, Germany; University of Marmara, Faculty of Medicine, Department of Physical and Rehabilitation Medicine, Rheumatology Clinics, Istanbul, Turkey; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Ottawa Hospital Research Institute, Ottawa; University Health Network (UHN)-Toronto Western Hospital, Toronto, Ontario

Development of Cardiovascular Quality Indicators for Rheumatoid Arthritis: Results from an International Expert Panel Using a Novel Online Process.
J Rheumatol 2015 Sep 15;42(9):1548-55. Epub 2015 Jul 15.
From the Division of Rheumatology, Department of Medicine, and the Department of Community Health Sciences, Arthur J.E. Child Chair in Rheumatology Research, the Division of Cardiology and the Department of Cardiovascular Sciences, and the Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta; Division of Cardiology and Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver; Arthritis Research Centre of Canada, Richmond, British Columbia; The RAND Corporation, Santa Monica, California, USA; Division of Rheumatology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada; Department of International Health, Johns Hopkins University School of Public Health, Baltimore, Maryland, USA.C.E. Barber, MD, FRCPC, PhD Candidate, Division of Rheumatology, Department of Medicine; D.A. Marshall, MHSA, PhD, Associate Professor, Department of Community Health Sciences, Arthur J.E. Child Chair in Rheumatology Research; N. Alvarez, MD, FRCPC, BA, Associate Professor, Division of Cardiology, Department of Cardiovascular Sciences, and Libin Cardiovascular Institute of Alberta, University of Calgary; G.B. Mancini, MD, FRCPC, Professor, Division of Cardiology; D. Lacaille, MD, FRCPC, MHSc, Professor, Division of Rheumatology, Department of Medicine, University of British Columbia and Senior Scientist, Arthritis Research Centre of Canada; S. Keeling, MD, FRCPC, MSc, Associate Professor, Division of Rheumatology, Department of Medicine, University of Alberta; J.A. Aviña-Zubieta, MD, MSc, PhD, Assistant Professor, Division of Rheumatology, Department of Medicine, University of British Columbia and Research Scientist, Arthritis Research Centre of Canada; D. Khodyakov, PhD, MA, Social/Behavioral Scientist, The RAND Corporation; C. Barnabe, MD, FRCPC, MSc, Assistant Professor, Division of Rheumatology, Department of Medicine, Department of Community Health Sciences, University of Calgary and ARC Research Sci


Heterogeneous Disease Trajectories Explain Variable Radiographic, Function and Quality of Life Outcomes in the Canadian Early Arthritis Cohort (CATCH).
PLoS One 2015 24;10(8):e0135327. Epub 2015 Aug 24.
Division of Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada; Hospital for Special Surgery, Weill Cornell Medical College, New York, New York, United States of America.

Fine particulate air pollution, nitrogen dioxide, and systemic autoimmune rheumatic disease in Calgary, Alberta.
Environ Res 2015 Jul 16;140:474-8. Epub 2015 May 16.
Department of Medicine, McGill University, Montreal, Quebec, Canada; Division of Clinical Epidemiology, McGill University Health Centre, Montreal, Quebec, Canada.


Imbalance of prevalence and specialty care for osteoarthritis for first nations people in Alberta, Canada.
J Rheumatol 2015 Feb 29;42(2):323-8. Epub 2014 Nov 29.
From the Department of Medicine and Department of Community Health Sciences, University of Calgary, Calgary; Department of Physical Therapy, and School of Public Health, University of Alberta, Edmonton, Alberta; Department of Medicine, and Department of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba; University of British Columbia, Vancouver; Arthritis Research Centre of Canada, Richmond, British Columbia; Divisions of Clinical Epidemiology and Rheumatology, Research Institute of the McGill University Health Centre, and Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.C. Barnabe, MD, MSc, FRCPC, Assistant Professor; B. Hemmelgarn, MD, PhD, FRCPC, Professor; D.A. Marshall, PhD, Associate Professor, Department of Medicine and Department of Community Health Sciences, University of Calgary; C.A. Jones, MSc(PT), PhD, Associate Professor, Department of Physical Therapy and School of Public Health; D. Voaklander, PhD, Professor, School of Public Health, University of Alberta; C.A. Peschken, MD, MSc, FRCPC, Associate Professor, Department of Medicine and Department of Community Health Sciences, University of Manitoba; L. Joseph, PhD, Professor, Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre, and Department of Epidemiology, Biostatistics and Occupational Health, McGill University; S. Bernatsky, MD, PhD, FRCPC, Associate Professor, Divisions of Clinical Epidemiology and Rheumatology, Research Institute of the McGill University Health Centre; J.M. Esdaile, MD, MPH, FRCPC, Professor, University of British Columbia, Arthritis Research Centre of Canada.

Invasive fungal disease in systemic lupus erythematosus: a systematic review of disease characteristics, risk factors, and prognosis.
Semin Arthritis Rheum 2014 Dec 26;44(3):325-30. Epub 2014 Jun 26.
Department of Medicine, University of Calgary, 3330 Hospital Dr NW, Calgary, Alberta, Canada T2N 4N1; Department of Community Health Sciences, University of Calgary, Alberta, Canada. Electronic address:

Age modification of diabetes-related hospitalization among First Nations adults in Alberta, Canada.
Diabetol Metab Syndr 2014 2;6(1):108. Epub 2014 Oct 2.
Department of Community Health Sciences, University of Calgary, Calgary, AB Canada ; Department of Medicine, University of Calgary, Calgary, AB Canada ; Interdisciplinary Chronic Disease Collaboration, Calgary, AB Canada ; Institute of Public Health, University of Calgary, Calgary, AB Canada ; Libin Cardiovascular Institute, University of Calgary, Calgary, AB Canada ; Foothills Medical Centre, Room C210, 3330 Hospital Dr. NW, Calgary, AB T2N 1N4 Canada.

The effect of different remission definitions on identification of predictors of both point and sustained remission in rheumatoid arthritis treated with anti-TNF therapy.
J Rheumatol 2014 Aug 15;41(8):1607-13. Epub 2014 Jul 15.
From the Department of Medicine, and the Department of Community Health Sciences, University of Calgary, Calgary; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.C. Barnabe, MD, MSc, FRPC, Assistant Professor, Department of Medicine, and the Department of Community Health Sciences, University of Calgary; J. Homik, MD, MSc, FRCPC, Associate Professor, Department of Medicine, University of Alberta; S.G. Barr, MD, MSC, FRCPC, Associate Professor; L. Martin, MB, ChB, FRCPC, Professor, Department of Medicine, University of Calgary; W.P. Maksymowych, MB, ChB, FRCPC, Professor, Department of Medicine, University of Alberta.

Effect of remission definition on healthcare cost savings estimates for patients with rheumatoid arthritis treated with biologic therapies.
J Rheumatol 2014 Aug 15;41(8):1600-6. Epub 2014 Jul 15.
From the Department of Medicine, University of Calgary, Calgary; Department of Community Health Sciences, University of Calgary, Calgary; Institute of Health Economics, Edmonton; School of Public Health, University of Alberta, Edmonton; and Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.C. Barnabe, MD, MSc, FRCPC, Department of Medicine and Department of Community Health Sciences, University of Calgary; N.X. Thanh, MD, PhD, MPH, Institute of Health Economics and School of Public Health, University of Alberta; A. Ohinmaa, PhD, Institute of Health Economics and School of Public Health, University of Alberta; J. Homik, MD, MSc, FRCPC, Department of Medicine, University of Alberta; S.G. Barr, MD, MSc, FRCPC, Department of Medicine, and Department of Community Health Sciences, University of Calgary; L. Martin, MB, ChB, FRCPC, Department of Medicine, University of Calgary; W.P. Maksymowych, MB, ChB, FRCPC, Department of Medicine, University of Alberta.

Discordant indigenous and provider frames explain challenges in improving access to arthritis care: a qualitative study using constructivist grounded theory.
Int J Equity Health 2014 Jun 11;13:46. Epub 2014 Jun 11.
Department of Community Health Sciences and Department of Ecosystem and Public Health, University of Calgary, 3280 Hospital Drive NW, Calgary T2N 4Z6, Canada.

Systemic autoimmune rheumatic disease prevalence in Canada: updated analyses across 7 provinces.
J Rheumatol 2014 Apr 1;41(4):673-9. Epub 2014 Mar 1.
From the Division of Clinical Epidemiology, and Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the McGill University Health Centre (MUHC), Montreal, Quebec; Division of Rheumatology, University of British Columbia, Vancouver, British Columbia; Department of Epidemiology and Biostatistics, and Division of Rheumatology, McGill University; Dalhousie University and Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia; Departments of Medicine and Community Health Sciences, University of Manitoba, and Repository, Manitoba Centre for Health Policy, Winnipeg, Manitoba; Centre for Chronic Disease Prevention, Public Health Agency of Canada, Ottawa, Ontario; Division of Rheumatology, University of Calgary, Calgary, Alberta; Centre de recherche du CHU de Québec, Faculté de médecine, Université Laval, Quebec City, Quebec; Chronic Disease Surveillance Division, National Institute of Public Health of Québec; Health Surveillance Branch, Public Health Division, Alberta Health and Wellness, Edmonton, Alberta; Divisions of Rheumatology, and Clinical Immunology/Allergy, Research Institute of the MUHC; Canadian Arthritis Patient Alliance; Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada.

Non-biologic disease-modifying antirheumatic drugs (DMARDs) improve pain in inflammatory arthritis (IA): a systematic literature review of randomized controlled trials.
Rheumatol Int 2013 May 6;33(5):1105-20. Epub 2013 Jan 6.
Division of Rheumatology, Toronto Western Hospital, University of Toronto, University Health Network, 399 Bathurst Street, Room 1E-420, Toronto, ON, M5T 2S8, Canada.

OF